MedTrace Logo

Bioavailability of Different Pramipexole Slow-release Formulations Compared to Immediate-release Tablet in Healthy Male Volunteers

NCT02261090 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 14

Last updated 2014-10-10

No results posted yet for this study

Summary

Study to compare the oral bioavailability of seven prototype slow-release formulations to immediate-release tablets

Conditions

  • Healthy

Interventions

DRUG

Formulation B: Pramipexole Slow release (SR) tablet

DRUG

Formulation C: Pramipexole Slow release tablet

DRUG

Formulation D: Pramipexole Slow release tablet

DRUG

Formulation E: Pramipexole Slow release tablet

DRUG

Formulation F: Pramipexole Slow release tablet

DRUG

Formulation G: Pramipexole Slow release tablet

DRUG

Formulation H: Pramipexole Slow release tablet

DRUG

Pramipexole immediate release (IR) tablets

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
21 Years
Max Age
50 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2004-06-30
Primary Completion
2004-09-30

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02261090 on ClinicalTrials.gov